SCHEMBL788369

SCHEMBL788369

COc1cc(N2N=C(Cl)c3ccccc3C2N)cc(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.39
GPBAR1 Q8TDU6 1/20 0.36
NPBWR1 P48145 2/20 0.35
MCHR1 Q99705 2/20 0.35
KDM1A O60341 1/20 0.35
GABRP O00591 4/20 0.34
GABRD O14764 4/20 0.34
GABRA1 P14867 4/20 0.34
GABRB1 P18505 4/20 0.34
GABRG2 P18507 4/20 0.34
GABRB3 P28472 4/20 0.34
GABRA5 P31644 4/20 0.34
GABRA3 P34903 4/20 0.34
GABRA2 P47869 4/20 0.34
GABRB2 P47870 4/20 0.34
GABRA4 P48169 4/20 0.34
GABRE P78334 4/20 0.34
GABRA6 Q16445 4/20 0.34
GABRG1 Q8N1C3 4/20 0.34
GABRG3 Q99928 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18001957 0.65 GPBAR1 (0.48) GPBAR1KDM1AGABRPGABRDGABRA1
SCHEMBL14054992 0.64 TMPRSS4 (0.46) NPBWR1MCHR1KDM1AGABRPGABRD
SCHEMBL5782136 0.62 ALDH1A1 (0.58) KDM1ATMPRSS4L3MBTL1ALDH1A1MAPT
SCHEMBL679095 0.62 ALDH1A1 (0.50) DPP4NPBWR1MCHR1KDM1ATMPRSS4
SCHEMBL787674 0.60 ALDH1A1 (0.43) ALDH1A1GAAMAPT
SCHEMBL18770617 0.60 NPBWR1 (0.50) NPBWR1MCHR1GABRPGABRDGABRA1
SCHEMBL16193422 0.60 ALDH1A1 (0.44) DPP4NPBWR1MCHR1KDM1APHGDH
SCHEMBL16398771 0.59 LTA4H (0.53) L3MBTL1MEN1ALDH1A1MAPTHPGD
SCHEMBL257565 0.59 RXRA (0.43) KDM1APHGDHTMPRSS4L3MBTL1ALDH1A1
SCHEMBL18052567 0.59 DPP4 (0.40) DPP4KDM1AL3MBTL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900656-A1 SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS Sunshine Lake Pharma Co., Ltd. (CN) 2015-08-05 EP disclosed
WO-2014019344-A1 BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2014-02-06 WO disclosed
EP-2616443-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS Exelixis, Inc. (US) 2013-07-24 EP disclosed
EP-2509960-A1 TGR5 AGONISTS Exelixis, Inc. (US) 2012-10-17 EP disclosed
WO-2012037132-A1 PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS EXELIXIS, INC. (US) 2012-03-22 WO disclosed
WO-2011071565-A1 TGR5 AGONISTS EXELIXIS, INC. (US) 2011-06-16 WO disclosed